Fresenius SE & Co. KGaA (OTCMKTS:FSNUY – Get Free Report) released its quarterly earnings results on Wednesday. The company reported $0.18 earnings per share (EPS) for the quarter, Zacks reports.
Fresenius SE & Co. KGaA Stock Down 0.8 %
OTCMKTS FSNUY traded down $0.07 during trading on Wednesday, hitting $9.69. The stock had a trading volume of 70,325 shares, compared to its average volume of 62,937. Fresenius SE & Co. KGaA has a one year low of $6.57 and a one year high of $10.15. The company has a quick ratio of 1.05, a current ratio of 1.36 and a debt-to-equity ratio of 0.57. The stock has a 50 day simple moving average of $9.31 and a 200 day simple moving average of $9.18.
Analyst Upgrades and Downgrades
Separately, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Fresenius SE & Co. KGaA in a report on Monday, February 3rd.
About Fresenius SE & Co. KGaA
Fresenius SE & Co KGaA, a health care company, provides products and services for chronically ill patients. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure.
Recommended Stories
- Five stocks we like better than Fresenius SE & Co. KGaA
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- AST SpaceMobile Stock Surges 17% After Analyst Upgrade
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- 3 Stocks With Triple-Digit PEs That Are Still Worth a Look
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- SMCI Investors Use These ETFs For Heightened Exposure
Receive News & Ratings for Fresenius SE & Co. KGaA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius SE & Co. KGaA and related companies with MarketBeat.com's FREE daily email newsletter.
